1. Antimicrobial Use in Patients with Dementia: Current Concerns and Future Recommendations

   • Carole Parsons
   • Jenny T. van der Steen

   Current Opinion 28 March 2017 Pages: 433 - 438

2. Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis

   • Gali Pariente
   • Tom Leibson
   • Irena Nulman

   Systematic Review 22 April 2017 Pages: 439 - 450

   

3. Erratum to: Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis

   • Gali Pariente
   • Tom Leibson
   • Irena Nulman

   Erratum 17 May 2017 Pages: 451 - 451

4. Cell Therapy for Multiple Sclerosis

   • Pamela Sarkar
   • Claire M. Rice
   • Neil J. Scolding

   Review Article 10 April 2017 Pages: 453 - 469

5. Achieving Smoking Cessation in Individuals with Schizophrenia: Special Considerations

   • Corinne Cather
   • Gladys N. Pachas
   • A. Eden Evins

   Review Article 26 May 2017 Pages: 471 - 481

6. Impact of Muscarinic M₃ Receptor Antagonism on the Risk of Type 2 Diabetes in Antidepressant-Treated Patients: A Case-Controlled Study

   • Yen-Hao Tran
   • Catharina C. M. Schuiling-Veninga
   • Bob Wilffert

   Original Research Article Open access 19 May 2017 Pages: 483 - 493

   

7. Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer’s Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data

   • Petr Kocis
   • Martin Tolar
   • John A. Hey

   Original Research Article Open access 24 April 2017 Pages: 495 - 509

   

8. Erratum to: Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD)

   • Katelyn R. Keyloun
   • Ryan N. Hansen
   • Emily Beth Devine

   Erratum 27 April 2017 Pages: 511 - 511

9. Cariprazine: A Review in Schizophrenia

   • Karly P. Garnock-Jones

   Adis Drug Evaluation 30 May 2017 Pages: 513 - 525